Johnson & Johnson $1.5B Talc Verdict
Analysis based on 7 articles · First reported Dec 23, 2025 · Last updated Dec 25, 2025
The significant legal verdict against Johnson & Johnson, ordering it to pay over $1.5 billion, is expected to negatively impact its stock price and overall market sentiment for the pharmaceutical and consumer goods industries. This event also highlights ongoing litigation risks for Johnson & Johnson and its subsidiaries like Kenvue and Pecos River Talc, potentially leading to increased legal provisions and uncertainty for investors.
A Baltimore jury awarded Cherie Craft over $1.5 billion in damages from Johnson & Johnson and its subsidiary Pecos River Talc, finding that the company's talc-based products caused her peritoneal mesothelioma. The verdict includes $59.84 million in compensatory damages and $1.5 billion in punitive damages. Johnson & Johnson, along with Kenvue, was found liable for failing to warn about asbestos in its baby powder. Johnson & Johnson has vowed to appeal the verdict, calling it 'egregious' and 'patently unconstitutional,' and maintains that its talc products are safe. This ruling is considered the largest-ever sum awarded against Johnson & Johnson for a single plaintiff in talc litigation, adding to the more than 67,000 lawsuits the company faces. Johnson & Johnson stopped selling talc-based baby powder in the United States in 2020 and globally in 2023, switching to cornstarch-based alternatives.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard